24820355|t|[Methohexital for analgosedation of ventilated intensive care patients : prospective nonrandomized single center observational study on incidence of delirium].
24820355|a|BACKGROUND: Delirium is defined by the Diagnostic and Statistical Manual of Mental Disorders, fourth edition, text revision (DSM-IV-TR) as a potentially reversible disturbance of consciousness and a change of cognition caused by a medical condition, drug intoxication, or medication side effect. Delirium affects up to 80 % of intensive care unit (ICU) patients and is associated with increased morbidity and mortality. One risk factor for development of delirium in ventilated intensive care unit patients is sedation. The German S3 guidelines on "Analgesie, Sedierung und Delirmanagement in der Intensivmedizin" (analgesia, sedation and delirium management in intensive care medicine) of the DGAI (German Society for Anesthesiology and Intensive Care Medicine) and the DIVI (German Interdisciplinary Association for Intensive Care and Emergency Medicine) recommend midazolam and propofol for sedation, although both drugs are associated with a high incidence of delirium. AIM: Within the framework of this study the question arose whether the barbiturate methohexital could be associated with a lower incidence of delirium in comparison to midazolam or propofol in analgosedated and ventilated ICU patients. MATERIAL AND METHODS: This was a prospective nonrandomized observational cohort study in a mixed medical surgical intensive care unit. Patients ventilated within 72 h after admittance were consecutively allocated to either propofol/remifentanil versus methohexital/remifentanil (expected ventilation duration <= 7 days) or midazolam/fentanyl versus methohexital/fentanyl (expected ventilation duration > 7 days) by the attending senior consultant anesthetist at the time of admission and/or intubation. Primary endpoint was delirium at any time during the ICU stay. Delirium was checked every 8 h by ICU nurses using the intensive care delirium screening checklist (ICDSC), with delirium defined as ICDSC >= 4 points. Before evaluation of the ICDSC the Richmond agitation sedation scale (RASS) score and the visual analogue scale for pain (VAS target <= 4) were measured. To assure reliable evaluation of the ICDSC, the RASS score of the patient at the time of evaluation had to be >= - 2. Assuming an incidence of delirium in the midazolam group of 70 % and in the methohexital group of 35 %, 16 patients were needed each in the midazolam/fentanyl and the methohexital/fentanyl cohorts (p = 0.05, beta = 0.1). Assuming an incidence of delirium in the propofol group of 50 % and in the methohexital group again of 35 %, 94 patients were needed in the propofol/remifentanil and methohexital/remifentanil groups, respectively (p = 0.05, beta = 0.1). RESULTS: A total of 222 patients were evaluated, 34 in the methohexital vs. midazolam group and 188 in the methohexital vs. propofol group. Out of 16 patients sedated with midazolam, 15 developed delirium (94 %) in contrast to only 5 out of 18 patients sedated with methohexital (28 %). Thus compared to midazolam the sedation with methohexital reduced the incidence of delirium by 66 % (p < 0.001) corresponding to a number needed to treat (NNT) of 1.5. Out of 94 patients in the propofol/remifentanil group, 64 developed delirium (68 %) in contrast to only 23 out of 94 in the methohexital/remifentanil group (24 %). Thus compared to propofol the sedation with methohexital reduced the incidence of delirium by 44 % (p < 0.001), corresponding to an NNT of 2.5. CONCLUSION: Sedation with methohexital compared to midazolam or propofol reduced the incidence of delirium by more than 50 % in ventilated ICU patients.
24820355	1	13	Methohexital	Chemical	MESH:D008723
24820355	62	70	patients	Species	9606
24820355	149	157	delirium	Disease	MESH:D003693
24820355	172	180	Delirium	Disease	MESH:D003693
24820355	236	252	Mental Disorders	Disease	MESH:D001523
24820355	324	352	disturbance of consciousness	Disease	MESH:D003244
24820355	456	464	Delirium	Disease	MESH:D003693
24820355	513	521	patients	Species	9606
24820355	615	623	delirium	Disease	MESH:D003693
24820355	658	666	patients	Species	9606
24820355	799	807	delirium	Disease	MESH:D003693
24820355	1027	1036	midazolam	Chemical	MESH:D008874
24820355	1041	1049	propofol	Chemical	MESH:D015742
24820355	1124	1132	delirium	Disease	MESH:D003693
24820355	1205	1216	barbiturate	Chemical	MESH:C032232
24820355	1217	1229	methohexital	Chemical	MESH:D008723
24820355	1276	1284	delirium	Disease	MESH:D003693
24820355	1302	1311	midazolam	Chemical	MESH:D008874
24820355	1315	1323	propofol	Chemical	MESH:D015742
24820355	1360	1368	patients	Species	9606
24820355	1505	1513	Patients	Species	9606
24820355	1593	1601	propofol	Chemical	MESH:D015742
24820355	1602	1614	remifentanil	Chemical	MESH:D000077208
24820355	1622	1634	methohexital	Chemical	MESH:D008723
24820355	1635	1647	remifentanil	Chemical	MESH:D000077208
24820355	1693	1702	midazolam	Chemical	MESH:D008874
24820355	1703	1711	fentanyl	Chemical	MESH:D005283
24820355	1719	1731	methohexital	Chemical	MESH:D008723
24820355	1732	1740	fentanyl	Chemical	MESH:D005283
24820355	1894	1902	delirium	Disease	MESH:D003693
24820355	1936	1944	Delirium	Disease	MESH:D003693
24820355	2006	2014	delirium	Disease	MESH:D003693
24820355	2049	2057	delirium	Disease	MESH:D003693
24820355	2132	2141	agitation	Disease	MESH:D011595
24820355	2204	2208	pain	Disease	MESH:D010146
24820355	2308	2315	patient	Species	9606
24820355	2385	2393	delirium	Disease	MESH:D003693
24820355	2401	2410	midazolam	Chemical	MESH:D008874
24820355	2436	2448	methohexital	Chemical	MESH:D008723
24820355	2467	2475	patients	Species	9606
24820355	2500	2509	midazolam	Chemical	MESH:D008874
24820355	2510	2518	fentanyl	Chemical	MESH:D005283
24820355	2527	2539	methohexital	Chemical	MESH:D008723
24820355	2540	2548	fentanyl	Chemical	MESH:D005283
24820355	2606	2614	delirium	Disease	MESH:D003693
24820355	2622	2630	propofol	Chemical	MESH:D015742
24820355	2656	2668	methohexital	Chemical	MESH:D008723
24820355	2693	2701	patients	Species	9606
24820355	2721	2729	propofol	Chemical	MESH:D015742
24820355	2730	2742	remifentanil	Chemical	MESH:D000077208
24820355	2747	2759	methohexital	Chemical	MESH:D008723
24820355	2760	2772	remifentanil	Chemical	MESH:D000077208
24820355	2842	2850	patients	Species	9606
24820355	2877	2889	methohexital	Chemical	MESH:D008723
24820355	2894	2903	midazolam	Chemical	MESH:D008874
24820355	2925	2937	methohexital	Chemical	MESH:D008723
24820355	2942	2950	propofol	Chemical	MESH:D015742
24820355	2968	2976	patients	Species	9606
24820355	2990	2999	midazolam	Chemical	MESH:D008874
24820355	3014	3022	delirium	Disease	MESH:D003693
24820355	3062	3070	patients	Species	9606
24820355	3084	3096	methohexital	Chemical	MESH:D008723
24820355	3122	3131	midazolam	Chemical	MESH:D008874
24820355	3150	3162	methohexital	Chemical	MESH:D008723
24820355	3188	3196	delirium	Disease	MESH:D003693
24820355	3283	3291	patients	Species	9606
24820355	3299	3307	propofol	Chemical	MESH:D015742
24820355	3308	3320	remifentanil	Chemical	MESH:D000077208
24820355	3341	3349	delirium	Disease	MESH:D003693
24820355	3397	3409	methohexital	Chemical	MESH:D008723
24820355	3410	3422	remifentanil	Chemical	MESH:D000077208
24820355	3454	3462	propofol	Chemical	MESH:D015742
24820355	3481	3493	methohexital	Chemical	MESH:D008723
24820355	3519	3527	delirium	Disease	MESH:D003693
24820355	3607	3619	methohexital	Chemical	MESH:D008723
24820355	3632	3641	midazolam	Chemical	MESH:D008874
24820355	3645	3653	propofol	Chemical	MESH:D015742
24820355	3679	3687	delirium	Disease	MESH:D003693
24820355	3724	3732	patients	Species	9606
24820355	Comparison	MESH:D008723	MESH:D008874
24820355	Negative_Correlation	MESH:C032232	MESH:D003693
24820355	Comparison	MESH:D005283	MESH:D008723
24820355	Cotreatment	MESH:D000077208	MESH:D015742
24820355	Positive_Correlation	MESH:D015742	MESH:D003693
24820355	Comparison	MESH:D008723	MESH:D015742
24820355	Cotreatment	MESH:D005283	MESH:D008874
24820355	Positive_Correlation	MESH:D008874	MESH:D003693
24820355	Comparison	MESH:D008874	MESH:D015742
24820355	Cotreatment	MESH:D005283	MESH:D015742
24820355	Negative_Correlation	MESH:D008723	MESH:D003693
24820355	Comparison	MESH:D000077208	MESH:D008723

